Halberd

Halberd Debt/Market Cap

The Debt to Market Capitalization Ratio of Halberd (HALB) as of Oct 23, 2026 is 18.17 %. In the previous year, Debt to Market Capitalization Ratio was 18.17 % — a change of 0.00% (lower).

Debt/Market Cap

18.17 %

YoY

0.00%

Last updated:

Debt to Market Capitalization Ratio of Halberd is 2025 18.17 % . Debt to Market Capitalization Ratio of Halberd was 2024 18.17 % . It decreases by 0.00% lower compared to the previous year.

The Halberd Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2016
82.90 USD
Jan 1, 2017
55.78 USD
Jan 1, 2021
18.17 USD
Jan 1, 2022
18.17 USD
Jan 1, 2023
18.17 USD
Jan 1, 2024
18.17 USD
Jan 1, 2025
18.17 USD
The Halberd Debt/Market Cap history
YEARDebt/Market CapYoY
18.17 %0.00%
18.17 %0.00%
18.17 %0.00%
18.17 %0.00%
18.17 %-67.42%
55.78 %-32.71%
82.90 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Halberd Stock analysis

What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Halberd stock

Debt to Market Capitalization Ratio of Halberd is 18.17 % in 2025.

Debt to Market Capitalization Ratio of Halberd changed from 18.17 % to 18.17 %, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio Halberd since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's Halberd with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Halberd

All Key Metrics — Halberd